1887

Journal of Medical Microbiology logo

Volume 61, Issue 6

Effect of 1-(1-naphthylmethyl)-piperazine on antimicrobial agent susceptibility in multidrug-resistant isogenic and veterinary field strains Free

Abstract

The objective of this study was to evaluate the interaction of the efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine (NMP) when combined with different families of antimicrobial agents against isogenic strains and multidrug-resistant (MDR) field strains isolated from animals. Laboratory isogenic strains of with different levels of expression of efflux pumps were used as quality controls. Ten MDR strains were collected from healthy animals in a cross-sectional study in four commercial dairy farms. The MICs of florfenicol, ciprofloxacin, tetracycline and ampicillin were determined by a serial microdilution method in Luria–Bertani broth in the presence or absence of NMP. NMP used with ampicillin exerted no effect on the isogenic or field strains. In most of the field MDR strains and in an -overexpressing (AG112) isogenic strain, the MICs of florfenicol, ciprofloxacin and tetracycline decreased at least fourfold when the antimicrobial was combined with the highest NMP concentrations. In the wild-type strain (AG100), there were no decreases of more than twice the MIC, whilst in strain AG100A, an efflux pump-deficient strain, the MIC did not change, regardless of the concentration of NMP used with these three antimicrobials. Thus, ampicillin was not affected by the efflux pump mechanism, whereas ciprofloxacin, tetracycline and florfenicol were shown to be substrates of efflux pumps, with a consequent significant reduction in MICs. Resistance could not be completely reversed in the field strains by NMP, probably because other resistance mechanisms were also present. However, in strain AG112, the MIC results demonstrated that NMP expressed an important synergistic activity with florfenicol. The reduction in florfenicol MIC value was sufficient to reverse antimicrobial resistance completely for AG112.

  • Received:
  • Accepted:
  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.040204-0
2012-06-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/6/786.html?itemId=/content/journal/jmm/10.1099/jmm.0.040204-0&mimeType=html&fmt=ahah

References

  1. Bean D. C., Wareham D. W. 2009; Paradoxical effect of 1-(1-naphthylmethyl)-piperazine on resistance to tetracyclines in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 63:349–352 [View Article][PubMed]
     [Google Scholar]
  2. Bina X. R., Philippart J. A., Bina J. E. 2009; Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae. J Antimicrob Chemother 63:103–108 [View Article][PubMed]
     [Google Scholar]
  3. Bohnert J. A., Kern W. V. 2005; Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 49:849–852 [View Article][PubMed]
     [Google Scholar]
  4. CLSI 2008 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals, 3rd edn. Approved Standard. M31-A3 Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  5. CLSI 2009 Performance Standards for Antimicrobial Susceptibility Testing 19th Informational Supplement. M100-S19 Wayne, PA: Clinical and Laboratory Standards Institute;
     [Google Scholar]
  6. Coban A. Y., Bayram Z., Sezgin F. M., Durupinar B. 2009; [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant Gram-negative bacteria]. Mikrobiyol Bul 43:457–461 (in Turkish) [PubMed]
     [Google Scholar]
  7. Cohen S. P., Hächler H., Levy S. B. 1993; Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J Bacteriol 175:1484–1492[PubMed]
     [Google Scholar]
  8. Delcour A. 2009; Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794:808–816 [View Article][PubMed]
     [Google Scholar]
  9. Elkins C. A., Nikaido H. 2002; Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol 184:6490–6498 [View Article][PubMed]
     [Google Scholar]
  10. Everett M. J., Jin Y. F., Ricci V., Piddock L. J. 1996; Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob Agents Chemother 40:2380–2386[PubMed]
     [Google Scholar]
  11. George A. M., Levy S. B. 1983; Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol 155:531–540[PubMed]
     [Google Scholar]
  12. Hannula M., Hänninen M. L. 2008; Effect of putative efflux pump inhibitors and inducers on the antimicrobial susceptibility of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 57:851–855 [View Article][PubMed]
     [Google Scholar]
  13. Kern W. V., Steinke P., Schumacher A., Schuster S., von Baum H., Bohnert J. A. 2006; Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother 57:339–343 [View Article][PubMed]
     [Google Scholar]
  14. Kriengkauykiat J., Porter E., Lomovskaya O., Wong-Beringer A. 2005; Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:565–570 [View Article][PubMed]
     [Google Scholar]
  15. Li X.-Z., Zhang L., Srikumar R., Poole K. 1998; β-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob Agents Chemother 42:399–403[PubMed]
     [Google Scholar]
  16. Lomovskaya O., Warren M. S., Lee A., Galazzo J., Fronko R., Lee M., Blais J., Cho D., Chamberland S. other authors 2001; Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45:105–116 [View Article][PubMed]
     [Google Scholar]
  17. Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T. 2000; Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44:3322–3327 [View Article][PubMed]
     [Google Scholar]
  18. Mazzariol A., Cornaglia G., Nikaido H. 2000; Contributions of the AmpC β-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K-12 to β-lactams. Antimicrob Agents Chemother 44:1387–1390 [View Article][PubMed]
     [Google Scholar]
  19. Moreira M., Souza E., Moraes C. 2004; Multidrug efflux systems in Gram-negative bacteria. Braz J Microbiol 35:19–28 [View Article]
     [Google Scholar]
  20. Nakae T., Nakajima A., Ono T., Saito K., Yoneyama H. 1999; Resistance to β-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and β-lactamase. Antimicrob Agents Chemother 43:1301–1303[PubMed]
     [Google Scholar]
  21. Nikaido H. 1996; Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 178:5853–5859[PubMed]
     [Google Scholar]
  22. Nikaido E., Yamaguchi A., Nishino K. 2008; AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J Biol Chem 283:24245–24253 [View Article][PubMed]
     [Google Scholar]
  23. Office International des Epizooties 2008 Collection and Shipment of Diagnostic Specimens. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 6th edn. Paris: Office International des Epizooties;
     [Google Scholar]
  24. Okusu H., Ma D., Nikaido H. 1996; AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 178:306–308[PubMed]
     [Google Scholar]
  25. Pannek S., Higgins P. G., Steinke P., Jonas D., Akova M., Bohnert J. A., Seifert H., Kern W. V. 2006; Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide. J Antimicrob Chemother 57:970–974 [View Article][PubMed]
     [Google Scholar]
  26. Poole K. 2005; Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20–51 [View Article][PubMed]
     [Google Scholar]
  27. Renau T. E., Léger R., Yen R., She M. W., Flamme E. M., Sangalang J., Gannon C. L., Chamberland S., Lomovskaya O., Lee V. J. 2002; Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa. Bioorg Med Chem Lett 12:763–766 [View Article][PubMed]
     [Google Scholar]
  28. Sáenz Y., Ruiz J., Zarazaga M., Teixidó M., Torres C., Vila J. 2004; Effect of the efflux pump inhibitor Phe-Arg-β-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother 53:544–545 [View Article][PubMed]
     [Google Scholar]
  29. Schumacher A., Steinke P., Bohnert J. A., Akova M., Jonas D., Kern W. V. 2006; Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother 57:344–348 [View Article][PubMed]
     [Google Scholar]
  30. Van Bambeke F., Glupczynski Y., Plésiat P., Pechère J. C., Tulkens P. M. 2003; Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother 51:1055–1065 [View Article][PubMed]
     [Google Scholar]
  31. Van Bambeke F., Pages J.-M., Lee V. J. 2010; Inhibitors of bacterial efflux pumps as adjuvants in antibacterial therapy and diagnostic tools for detection of resistance by efflux. Front Anti-Infect Drug Discov 1:138–175 [View Article]
     [Google Scholar]
  32. Webber M. A., Piddock L. J. 2003; The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51:9–11 [View Article][PubMed]
     [Google Scholar]
  33. Ziha-Zarifi I., Llanes C., Köhler T., Pechere J. C., Plesiat P. 1999; In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother 43:287–291[PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.040204-0
Loading
Effect of 1-(1-naphthylmethyl)-piperazine on antimicrobial agent susceptibility in multidrug-resistant isogenic and veterinary Escherichia coli field strains
J. Med. Microbiol. 61, 786 (2012); https://doi.org/10.1099/jmm.0.040204-0
/content/journal/jmm/10.1099/jmm.0.040204-0
/content/journal/jmm/10.1099/jmm.0.040204-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error